138 related articles for article (PubMed ID: 37288826)
21. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
23. Blastoid Mantle Cell Lymphoma.
Jain P; Wang M
Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288
[TBL] [Abstract][Full Text] [Related]
24. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
[TBL] [Abstract][Full Text] [Related]
25. TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
Kim DH; Siddiqui S; Jain P; Wang M; Thakral B; Li S; Miranda R; Vega F; Medeiros LJ; Ok CY
Hum Pathol; 2024 Apr; 146():1-7. PubMed ID: 38460798
[TBL] [Abstract][Full Text] [Related]
26. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
27. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value and computer image analysis of p53 in mantle cell lymphoma.
Zhang YH; Gao LM; Xiang XY; Zhang WY; Liu WP
Ann Hematol; 2022 Oct; 101(10):2271-2279. PubMed ID: 35918462
[TBL] [Abstract][Full Text] [Related]
29. NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Deshotels L; Safa FM; Saba NS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427
[TBL] [Abstract][Full Text] [Related]
30. Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell Lymphoma.
Chuang WY; Yu WH; Lee YC; Zhang QY; Chang H; Shih LY; Yeh CJ; Lin SM; Chang SH; Ueng SH; Wang TH; Hsueh C; Kuo CF; Chuang SS; Yeh CY
Am J Pathol; 2022 Dec; 192(12):1763-1778. PubMed ID: 36150505
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of CKS-1B in typical and blastoid variants of mantle cell lymphoma.
Akyurek N; Drakos E; Giaslakiotis K; Knoblock RJ; Abruzzo LV; Ning Y; Rassidakis GZ; Medeiros LJ
Hum Pathol; 2010 Oct; 41(10):1448-55. PubMed ID: 20688354
[TBL] [Abstract][Full Text] [Related]
34. Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.
Loungani L; Mundhe R; Chinoy R
Int J Surg Pathol; 2022 Apr; 30(2):190-194. PubMed ID: 34180720
[TBL] [Abstract][Full Text] [Related]
35. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
[No Abstract] [Full Text] [Related]
37. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients.
Miao Y; Lin P; Saksena A; Xu J; Wang M; Romaguera J; Yin CC; Medeiros LJ; Li S
Am J Surg Pathol; 2019 Aug; 43(8):1052-1060. PubMed ID: 31045891
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
39. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
40. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
